Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

3.670

-0.100 (-2.65%)

At close: Feb 27, 2026, 4:00 PM EST

3.653

-0.017 (-0.45%)

After-hours: Feb 27, 2026, 7:57 PM EST

Recursion Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,939	2,129	2,666	2,136	1,461	2,895
Market Cap Growth	-35.84%	-20.16%	24.83%	46.15%	-49.52%	-
Enterprise Value	1,273	1,551	2,329	1,800	1,059	2,317
Last Close Price	3.67	4.09	6.76	9.86	7.71	17.13
PS Ratio	25.96	28.50	45.32	47.92	36.68	284.42
PB Ratio	1.71	1.88	2.58	4.61	3.01	5.33
P/TBV Ratio	2.94	3.23	4.85	5.70	3.02	5.35
EV/Sales Ratio	17.05	20.77	39.59	40.38	26.58	227.62
Debt / Equity Ratio	0.07	0.07	0.11	0.11	0.11	0.00
Net Debt / Equity Ratio	-0.59	-0.59	-0.47	-0.74	-1.03	-0.95
Net Debt / EBITDA Ratio	1.18	1.18	1.10	1.05	2.13	2.96
Net Debt / FCF Ratio	1.76	1.76	1.30	1.14	4.14	2.60
Asset Turnover	0.05	0.05	0.06	0.07	0.06	0.02
Quick Ratio	5.20	5.20	3.43	4.24	5.51	11.27
Current Ratio	5.50	5.50	3.81	4.70	5.68	11.46
Return on Equity (ROE)	-59.54%	-59.54%	-61.90%	-69.12%	-46.56%	-47.51%
Return on Assets (ROA)	-27.72%	-27.72%	-28.48%	-32.29%	-23.42%	-25.14%
Return on Capital Employed (ROCE)	-48.90%	-48.90%	-38.00%	-62.50%	-40.90%	-32.40%
Earnings Yield	-33.26%	-30.29%	-17.39%	-15.36%	-16.39%	-6.44%
FCF Yield	-19.51%	-17.77%	-13.98%	-14.03%	-8.25%	-6.85%
Buyback Yield / Dilution	-63.18%	-63.18%	-31.92%	-18.41%	-40.04%	-475.48%

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q